DiaSpect Control HBT2 7049-6212
DiaSpect Control HBT2 7049-6212 (900-502) is a medical device (FDA Class II; FDA product code GGM, Control, Hemoglobin) made by EKF-diagnostic GmbH, listed in FDA GUDID since 12 Mar 2021 (UDI-DI 14048534001981), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number14048534001981 | Date12 Mar 2021 | StatusListed |
Official records
- AccessGUDID record 14048534001981
From the FDA record
- Device description
- For the verification of the precision and accuracy of DiaSpect Tm and DiaSpect Tm Cuvettes
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- DiaSpect Control HBT2
- Generic name
- Total haemoglobin (totHb) IVD, control
- Model / Ref / Catalog
- 7049-6212, 900-502
- Primary DI / UDI-DI
- 14048534001981
- FDA product code
- GGM
- GMDN term
- Total haemoglobin (totHb) IVD, control
- Device class
- Class II
- Regulation number
- 864.8625
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code GGM (Control, Hemoglobin).
- Research and Diagnostic Systems GH00LX by RESEARCH AND DIAGNOSTIC SYSTEMS, INC.
- GLYCOHEMOSURE HBA1C CONTROL by QUANTIMETRIX CORP.
- HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo High by Eurotrol B.V.
- HemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - High by Eurotrol B.V.
- CRITERION, HEMOCUE B-HEMOGLOBIN CONTROL by Isolab, Inc.
- Research and Diagnostic Systems HCLNH3 by RESEARCH AND DIAGNOSTIC SYSTEMS, INC.
- HGB-CONTROL SET/MULTIPLE by R&D Systems, Inc.
- R&D SICKLE QC CONTROL by R&D Systems, Inc.
- PRECINORM HB by Boehringer Mannheim Corp.
- HEMOGLOBIN CONTROLS by Electrophoresis Corp.